Kallyope: Funding, Investors & Team (Oct 2026)
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. The gut-brain axis the communication highway between our gut and our brain offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes. An understanding of the biology mediated by the gut and gut-brain circuits will change the way we think about food, nutrition, and human physiology.
Kallyope has raised $450M across 4 funding rounds on record, the most recent an undisclosed round of $94.0M announced in Oct 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kallyope Company Profile and Key Stats
Latest funding round on record: Oct 2026.
Kallyope Funding Rounds
Kallyope raised $112M in an undisclosed round announced in Mar 2020.
1.9 years later, a Series D of $236M was announced in Feb 2022.
1.3 years later, an undisclosed round of $8.2M was announced in May 2023.
3.4 years later, an undisclosed round of $94.0M was announced in Oct 2026.
Kallyope Investors
21 investors are recorded in total; the 5 named above are those the record identifies.
Kallyope Founders and Leadership Team
Contact details for the Kallyope team: 3 of 4 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Kallyope Funding Compared to Other Biotechnology Startups
Kallyope's latest round of $94.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kallyope in Biotechnology and New York
Companies Similar to Kallyope
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Kallyope Funding FAQs
What does Kallyope do?
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. The gut-brain axis the communication highway between our gut and our brain offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes. An understanding of the biology mediated by the gut and gut-brain circuits will change the way we think about food, nutrition, and human physiology.
How much funding has Kallyope raised?
Kallyope has raised $450M across 4 rounds on record. The most recent is an undisclosed round of $94.0M announced in Oct 2026.
When did Kallyope last raise funding?
Kallyope's most recent funding round on record is an undisclosed round of $94.0M, announced in Oct 2026.
Who has invested in Kallyope?
Investors on record for Kallyope include Lux Capital, StepStone Group, TCG Crossover, Mubadala, Illumina Ventures. FundedIQ records 21 investors in total.
Who founded Kallyope?
FundedIQ lists Tom Maniatis (Founder) at Kallyope.
Who is the CEO of Kallyope?
Nancy Thornberry is listed as CEO at Kallyope.
Where is Kallyope headquartered?
Kallyope is based in New York, United States.
How many employees does Kallyope have?
Kallyope is in the 51-100 employee band.
When was Kallyope founded?
Kallyope was founded in 2015.
How does Kallyope's funding compare to other Biotechnology startups?
Kallyope's latest round of $94.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kallyope Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kallyope is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.